Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
30/04/2025
Qorvo's adjusted revenue for the fourth quarter was $8.695 billion, exceeding analysts' expectations of $8.508 billion.
Latest
2 m ago
Samsung Electronics' first-quarter operating profit increased slightly.
2 m ago
According to the AI quick news, Tianfeng Securities released a research report on April 30th, giving Baoneng Energy (000690.SZ) a buy rating. The main reasons for the rating include: 1) The overall electricity price has declined, leading to a decrease in fuel costs driven by the decline in coal prices; 2) High growth in performance in 2025Q1, with the prospect of further reduction in fuel costs; 3) The construction of the second phase of the Jiahewan project in Lufeng is underway, with a considerable increase in installed capacity. (Daily Economic News)
3 m ago
Xingchen Technology: AI glasses customer end products are expected to ship in the second half of the year.
7 m ago
Samsung Electronics announced its first quarter performance, and the stock price fell by 0.1% to 55,750 Korean won.
10 m ago
Bayer wins U.S. patent dispute, USPTO rules Pharmacyclics patent invalid.
See all latest